Professor, Pediatrics, University of California, Irvine College of Medicine and Medical Director and Founder of The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders
Pediatric Hematology & Oncology
Diane Nugent, MD is an expert in the field of Pediatric Hematology & Oncology. She graduated from David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care She received awards:"Circle of Care Award'", "Best Doctors in America", "Physician of the Year", "Physician of the Year Award", "Best Doctors in Orange Co. Award", "Physician's CARE Award", "Teacher of the Year", "Academic Faculty Research Award", "Outstanding Academic Faculty", "Poncin Scholarship Award", "Outstanding Clinical Faculty", "Golden Apple Teaching Award", "Bruce Graber Memorial Award for Outstanding Resident in Pediatrics" and "Super Doctor". Diane Nugent has written publications. She has 64 publications published with PubMed. The lastest publication is: 'Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia.'
Publications
- Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi Anemia.
- Changes in bleeding patterns in von Willebrand Disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
- Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
- Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
- Identification of Patients with RAG Mutations Previously Diagnosed with Common Variable Immunodeficiency Disorders.
- Successful treatment of post-transplant thrombocytopenia with romiplostim in a pediatric patient with X-linked chronic granulomatous Disease.
- Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children.
- Effects of hematopoietic stem Cell transplantation on acyl-CoA oxidase deficiency: a sibling comparison study.
- Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial Cells.
- Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics.
- Newborn screening for severe combined immunodeficiency: an opportunity for intervention.
- Associations between inhibitors, treatment regimen, and bleed frequency and health care practitioner utilisation in the haemophilia treatment centre (HTC): Global resu...
- Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.
- Successful autologous cord blood transplantation in a child with acquired severe aplastic Anemia.
- Successful cord blood transplantation in a patient with malignant infantile osteopetrosis and Hemophilia.
- Conditional knockout of integrin alpha2beta1 in murine megakaryocytes leads to reduced mean Platelet volume.
- Preparticipation cardiovascular screening among National Collegiate Athletic Association Division I Institutions.
- Prophylaxis in severe forms of von Willebrand's Disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
- Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
- Late effects in hematopoietic cell transplant recipients with acquired severe aplastic Anemia: a report from the late effects working committee of the center for inter...
- Genetic variants that affect Platelet function.
- Rare factor deficiencies.
- Inflammatory polyps following successful HLA-matched cord blood transplantation in a patient with X-linked lymphoproliferative syndrome.
- X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype.
- Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.
- Platelet adhesion to decorin but not collagen I correlates with the integrin ?2 dimorphism E534K, the basis of the human Platelet alloantigen (HPA) -5 system.
- The international factor IX treatment network survey.
- Psychosocial aspects of haemophilia: a systematic review of methodologies and findings.
- Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic Anemia and iron overload.
- Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with Hemophilia.
- The principal results of the International Immune Tolerance Study: a randomized dose comparison.
- Mean Platelet Volume and Integrin Alleles Correlate With Levels of Integrins ?IIb?3 and ?2?1 in Acute Coronary Syndrome Patients and Normal Subjects.
- Response to steroids predicts response to rituximab in pediatric chronic Immune thrombocytopenia.
- Newly diagnosed Immune thrombocytopenia in children and adults, a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocyto...
- A patient with familial bone marrow failure and an inversion of chromosome 8.
- Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics?
- FondaKIDS: A prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age.
- A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with Immune thrombocytopenia.
- Surveillance of female patients with inherited bleeding Disorders in United States Haemophilia Treatment Centres.
- The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma.
- Screening for von Willebrand Disease in children: a case-control study.
- Standardization of thromboelastography: a report from the TEG-ROTEM working group.
- The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A.
- Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.
- von Willebrand factor: what is its role in the Immune response in haemophilia?
- The genetics of normal Platelet reactivity.
- Living Profiles: design of a health media platform for teens with special healthcare needs.
- Comparison of kaolin and tissue factor activated thromboelastography in haemophilia.
- Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study.
- The use of inductively coupled plasma-atomic emission spectroscopy (ICP-AES) in the determination of lithium in cleaning validation swabs.
- Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
- Enhanced binding of poly(ADP-ribose)polymerase-1 and Ku80/70 to the ITGA2 promoter via an extended cytosine-adenosine repeat.
- Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for...
- Genetics of Platelet reactivity in normal, healthy individuals.
- Pathogenesis of chronic Immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
- The low-frequency isoform of Platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.
- Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children.
- Factor XIII deficiency.
- Platelet function defects.
- Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular Disease.
- A review of islet of Langerhans degeneration in rodent models of type 2 diabetes.
- Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe Hemophilia A.
- Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
University Of Co School Of Med
University Wa Med Center
Procedures Preformed
Conditions Treated
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Deep Vein Thrombosis (DVT)
- ENT Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Circle of Care Award'
- Best Doctors in America
- Physician of the Year
- Physician of the Year Award
- Best Doctors in Orange Co. Award
- Physician's CARE Award
- Teacher of the Year
- Academic Faculty Research Award
- Outstanding Academic Faculty
- Poncin Scholarship Award
- Outstanding Clinical Faculty
- Golden Apple Teaching Award
- Bruce Graber Memorial Award for Outstanding Resident in Pediatrics
- Super Doctor
Education
-
University of Washington
-
University of Colorado
-
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
-
UC Irvine Medical Center
-
Children's Hospital of Orange County
-
St. Joseph Hospital
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.